Innovative research by Bustoros et al. has attempted to refine our understanding of SMM progression by integrating genetic information from targeted next-generation sequencing. This work identified associations between the risk of progression and mutations in pathways such as MAPK (KRAS and NRAS SNVs), DNA repair (Deletion 17p, TP53, and ATM SNVs), and MYC (translocations and copy number variations). Moreover, APOBEC-associated mutations were found to be enriched in the progressed group and linked to shorter time to progression[17]. These integrated genetic models have demonstrated improved predictability of progression, as validated by their performance in external cohorts